Sycamore Partners is in talks to acquire struggling drugstore chain Walgreens Boots Alliance Inc., according to people familiar with the matter.
The New York-based private equity firm has been having ongoing discussions about a deal to take Walgreens private, said the people, who asked to not be identified because the details aren’t public. It’s possible discussions could fall through without a deal materializing, the people added.
The stock jumped as much as 28 percent on the news, which was first reported by the Wall Street Journal. That was its biggest single-day gain since at least 1980. Walgreens shares had lost two-thirds of their value over the course of the year through Monday. That’s the worst performance of any stock in the S&P 500.
The stock was up 20 percent at 1:48 pm in New York Tuesday, giving the company a market value of about $9.2 billion.
Representatives for Walgreens and Sycamore Partners declined to comment.
In October, the pharmacy chain said it would be closing some 1,200 outlets over the next three years after posting a $3 billion loss in the fourth quarter on charges related to opioid liabilities and the write-down of an investment in China. The company’s retail division has struggled amid the rise of online retailers like Amazon.com and discount giants Dollar General and Costco.
Walgreens has been a take-private candidate for years. KKR & Co. formally approached the drugstore giant about a deal in 2019 in partnership with current chairman and biggest shareholder Stefano Pessina when the firm had a market value of $56 billion. Sycamore Partners has a history of acquiring retailers that have seen better times, including office supplier Staples Inc. and department-store chain Belk Inc.
By Gillian Tan and Cynthia Koons
Learn more:
Walgreens Plans to Shutter 14% of US Stores Over Three Years
As part of ongoing cost-cutting measures, the drugstore chain will trim 1,200 locations from its north American store footprint.
